WHO ICTRP trial

Feasibility and Efficacy of using a non-invasive pain numbing device in…

ACTRN12617000950369 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not recruiting

Key facts

Trial ID ACTRN12617000950369
Public title Feasibility and Efficacy of using a non-invasive pain numbing device in Australian Blood Donor Centres - Part 1
Scientific title An investigator initiated, prospective, non-randomised study to assess the feasibility and efficacy of using the pain numbing device Coolsense (R) on pain and anxiety in Australian adult Blood Donors
Primary sponsor Australian Red Cross Blood Service
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not recruiting
Study type Interventional
Phase Phase 4
Conditions Blood Donation
Interventions The aim of the study is to assess the feasibility of using a pain numbing device or injection site desensitiser for venepuncture performed in Australian Blood Donor centers for whole blood collections. The Intervention to be evaluated is a…
Registration date Mar 7, 2017
Target size 50
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations